Regulation of quinolinic acid in the normal rat brain by kynurenine pathway precursors.
Preclinical R&D, Astra Arcus AB, Södertälje, Sweden.
J
J
Luthman
E
E
Vänerman
G
G
Fredriksson
B
B
Fornstedt-Wallin
D015095:3-Hydroxyanthranilic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology; D000704:Analysis of Variance; D000818:Animals; D002552:Cerebral Ventricles / Q000187:drug effects / Q000502:physiology; D006624:Hippocampus / Q000378:metabolism*; D007274:Injections, Intraperitoneal; D007276:Injections, Intraventricular; D007279:Injections, Subcutaneous; D007737:Kynurenine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000378:metabolism*; D008297:Male; D017378:Quinolinic Acid / Q000008:administration & dosage / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013237:Stereoisomerism; D014364:Tryptophan / Q000008:administration & dosage / Q000378:metabolism*
C104255:4,6-dibromo-3-hydroxyanthranilic acid; D015095:3-Hydroxyanthranilic Acid; D007737:Kynurenine; D014364:Tryptophan; D017378:Quinolinic Acid